As applications of generative AI (GenAI), and AI in general, extend to every industry, the dialogue surrounding its responsible integration remains front and centre.
According to Takeda Pharmaceuticals, the average time taken to diagnose a rare disease without technology is 7.6 years, and that comes after countless tests and physician visits.
In the dynamic realm of modern pharmaceuticals, the convergence of artificial intelligence (AI) has emerged as a transformative catalyst, propelling companies towards unparalleled competiti
Scientists have developed a new test for a biomarker in brain tissue that could detect people who will go on to develop motor neuron disease (MND) before they show symptom